Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin Tissue PK in Skin Inflammation and Infection
NCT06170983Not yet recruiting
- Sponsor
- Medical University of Vienna
- Start
- Jan 2024
- Primary completion
- Jan 2026
- Modality
- Small Molecules
01
Overview
Open-label trial of azithromycin in erysipelas and cellulitis (3 arms), sponsored by Medical University of Vienna. Primary endpoints: Area under the curve at Day 3 and Maximum concentration at Day 3. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
azithromycin
03
Conditions
erysipelascellulitis
Beyond the preview
Go deeper on NCT06170983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06170983.